Speech disorders impacting children have debilitating impacts on educational, social and later employment outcomes. There are limited therapeutic options for...
Redenlab, a leading provider of innovative solutions in the field of pediatric and neurodevelopment communication, proudly announces that Professor Angela...
L16HTHOUSE is a research trial testing an experimental medication for treating speech, motor, learning, and other developmental delays in children...
Speech and language development is a complex, multifactorial process driven by the individual’s ability to process and formulate communication. These...
Rare genetically inherited neurodevelopmental disorders remain a huge diagnostic and therapeutic challenge in clinical medicine. Redenlab pediatric consultant Prof Angela...
To explore the characteristics and associated factors of oromotor dysfunction in minimally verbal children with cerebral palsy (CP) aged five...
There is a lack of population‐based studies exploring the communicative behaviours of minimally verbal children with cerebral palsy (CP), with...
To examine the frequency, characteristics, and factors associated with speech delay and disorder in a community sample of children with...
Objective Determining the genetic basis of speech disorders provides insight into the neurobiology of human communication. Despite intensive investigation over the...
What this paper adds Speech and voice outcomes were similar between children born preterm and at term. Male sex, high...